U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    Spry2 sprouty RTK signaling antagonist 2 [ Mus musculus (house mouse) ]

    Gene ID: 24064, updated on 14-Nov-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    Multiple endocrine defects in adult-onset Sprouty1/2/4 triple knockout mice.

    Multiple endocrine defects in adult-onset Sprouty1/2/4 triple knockout mice.
    Altés G, Olomí A, Perramon-Güell A, Hernández S, Casanovas A, Pérez A, Díaz-Tocados JM, Valdivielso JM, Megino C, Navaridas R, Matias-Guiu X, Klein OD, Egea J, Dolcet X, Yeramian A, Encinas M., Free PMC Article

    10/3/2024
    Loss of SPRY2 contributes to cancer-associated fibroblasts activation and promotes breast cancer development.

    Loss of SPRY2 contributes to cancer-associated fibroblasts activation and promotes breast cancer development.
    Dai H, Xu W, Wang L, Li X, Sheng X, Zhu L, Li Y, Dong X, Zhou W, Han C, Mao Y, Yao L., Free PMC Article

    09/8/2023
    Deep Crypt Secretory Cell Differentiation in the Colonic Epithelium Is Regulated by Sprouty2 and Interleukin 13.

    Deep Crypt Secretory Cell Differentiation in the Colonic Epithelium Is Regulated by Sprouty2 and Interleukin 13.
    Schumacher MA, Liu CY, Katada K, Thai MH, Hsieh JJ, Hansten BJ, Waddell A, Rosen MJ, Frey MR., Free PMC Article

    03/24/2023
    Loss of Sprouty Produces a Ciliopathic Skeletal Phenotype in Mice Through Upregulation of Hedgehog Signaling.

    Loss of Sprouty Produces a Ciliopathic Skeletal Phenotype in Mice Through Upregulation of Hedgehog Signaling.
    Hruba E, Kavkova M, Dalecka L, Macholan M, Zikmund T, Varecha M, Bosakova M, Kaiser J, Krejci P, Hovorakova M, Buchtova M.

    01/1/2022
    Sprouty2 positively regulates T cell function and airway inflammation through regulation of CSK and LCK kinases.

    Sprouty2 positively regulates T cell function and airway inflammation through regulation of CSK and LCK kinases.
    Sripada A, Sirohi K, Michalec L, Guo L, McKay JT, Yadav S, Verma M, Good J, Rollins D, Gorska MM, Alam R., Free PMC Article

    07/31/2021
    Sprouty2 limits intestinal tuft and goblet cell numbers through GSK3beta-mediated restriction of epithelial IL-33.

    Sprouty2 limits intestinal tuft and goblet cell numbers through GSK3β-mediated restriction of epithelial IL-33.
    Schumacher MA, Hsieh JJ, Liu CY, Appel KL, Waddell A, Almohazey D, Katada K, Bernard JK, Bucar EB, Gadeock S, Maselli KM, Washington MK, Grikscheit TC, Warburton D, Rosen MJ, Frey MR., Free PMC Article

    02/20/2021
    Using the developing long bone as a model organ, the effects of Spry2 deletion on osteogenic cells appear complex in part because of its ubiquitous expression and also due to the multiple cell-specific effects of the encoded protein

    Specification of Sprouty2 functions in osteogenesis in in vivo context.
    Vesela B, Svandova E, Hovorakova M, Peterkova R, Kratochvilova A, Pasovska M, Ramesova A, Lesot H, Matalova E., Free PMC Article

    05/16/2020
    Results suggest that Sprouty2 is involved in the control of osteoblast proliferation and differentiation by downregulating the FGF-ERK1/2 and BMP-Smad pathways, and suppresses the induction of markers of osteoblast differentiation.

    Sprouty2 is involved in the control of osteoblast proliferation and differentiation through the FGF and BMP signaling pathways.
    Taketomi T, Onimura T, Yoshiga D, Muratsu D, Sanui T, Fukuda T, Kusukawa J, Nakamura S.

    11/9/2019
    Loss of Spry1/2 enhances the survival of effector CD8+ T cells and results in the formation of more protective memory cells. Deleting Spry1/2 in antigen-specific CD8+ T cells may have therapeutic potential for enhancing the survival and functionality of effector and memory CD8+ T cells in vivo.

    Lack of Sprouty 1 and 2 enhances survival of effector CD8(+) T cells and yields more protective memory cells.
    Shehata HM, Khan S, Chen E, Fields PE, Flavell RA, Sanjabi S., Free PMC Article

    10/13/2018
    These results identify Spry2 as a critical regulator of endochondral bone formation that modulates signaling in both osteoblast and chondrocyte lineages.

    Sprouty2 regulates endochondral bone formation by modulation of RTK and BMP signaling.
    Joo A, Long R, Cheng Z, Alexander C, Chang W, Klein OD., Free PMC Article

    12/23/2017
    MYB acts on MAPK signaling by directly regulating transcription of the gene encoding the negative modulator SPRY2.

    Transcriptional regulation of SPROUTY2 by MYB influences myeloid cell proliferation and stem cell properties by enhancing responsiveness to IL-3.
    Clarke M, Volpe G, Sheriff L, Walton D, Ward C, Wei W, Dumon S, García P, Frampton J., Free PMC Article

    10/14/2017
    Spry2 is a novel unfolded protein response target and its upregulation is dependent on PERK. Knockdown of Spry2 resulted in reduced expression of Serca2, reduced endoplasmic reticulum calcium levels, and induction of the UPR. Spry2 deletion in the adult mouse beta-cell caused hyperglycemia and hypoinsulinemia.

    A Whole-Genome RNA Interference Screen Reveals a Role for Spry2 in Insulin Transcription and the Unfolded Protein Response.
    Pappalardo Z, Gambhir Chopra D, Hennings TG, Richards H, Choe J, Yang K, Baeyens L, Ang K, Chen S, Arkin M, German MS, McManus MT, Ku GM., Free PMC Article

    08/26/2017
    these results establish SPRY2 as a critical negative regulator of BCR-mediated MAPK-Erk signaling in chronic lymphocytic leukemia , thereby providing one of the molecular mechanisms to explain the clinical heterogeneity of chronic lymphocytic leukemia.

    Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL.
    Shukla A, Rai K, Shukla V, Chaturvedi NK, Bociek RG, Pirruccello SJ, Band H, Lu R, Joshi SS., Free PMC Article

    06/24/2017
    In the present study, it is demonstrated that Spry2 and -4 participate in KA induced neurodegeneration possibly through inhibition of ERK signaling.

    Sprouty2 and -4 hypomorphism promotes neuronal survival and astrocytosis in a mouse model of kainic acid induced neuronal damage.
    Thongrong S, Hausott B, Marvaldi L, Agostinho AS, Zangrandi L, Burtscher J, Fogli B, Schwarzer C, Klimaschewski L., Free PMC Article

    01/14/2017
    Study revealed that suppression of Spry2 expression induced proliferation and differentiation of osteoblastic cells upon bFGF and EGF stimulation, whereas it diminished proliferation of gingival epithelial cells.

    Mutation of Spry2 induces proliferation and differentiation of osteoblasts but inhibits proliferation of gingival epithelial cells.
    Sanui T, Tanaka U, Fukuda T, Toyoda K, Taketomi T, Atomura R, Yamamichi K, Nishimura F.

    03/26/2016
    Cosuppression of Sprouty and Sprouty-related negative regulators of FGF signalling in prostate cancer

    Cosuppression of Sprouty and Sprouty-related negative regulators of FGF signalling in prostate cancer: a working hypothesis.
    Assinder SJ, Beniamen D, Lovicu FJ., Free PMC Article

    03/5/2016
    in embryos with lower Spry2;Spry4 gene dosages, we observed a non-fusion of original R2 and M1 Shh signaling domains with consequent formation of a supernumerary tooth primordium from the isolated R2 bud

    Sprouty gene dosage influences temporal-spatial dynamics of primary enamel knot formation.
    Lochovska K, Peterkova R, Pavlikova Z, Hovorakova M., Free PMC Article

    01/30/2016
    The data showed enhanced axon outgrowth and improved long-distance axon regeneration in sprouty2 deficient mice

    Enhanced axon outgrowth and improved long-distance axon regeneration in sprouty2 deficient mice.
    Marvaldi L, Thongrong S, Kozłowska A, Irschick R, Pritz CO, Bäumer B, Ronchi G, Geuna S, Hausott B, Klimaschewski L.

    10/10/2015
    Sprouty2 acts as an inhibitor of CrkL-Rap1 signaling.

    CrkL is a novel target of Sprouty2 in fibroblast growth factor signaling.
    Satoh T, Torii S, Nakayama K, Nishida E.

    07/4/2015
    we reveal that SPRY2 expression is regulated by FOXO3a and beta-catenin nuclear activity in colon cancer

    SPROUTY2 is a β-catenin and FOXO3a target gene indicative of poor prognosis in colon cancer.
    Ordóñez-Morán P, Irmisch A, Barbáchano A, Chicote I, Tenbaum S, Landolfi S, Tabernero J, Huelsken J, Muñoz A, Pálmer HG.

    05/31/2014
    Spry1 and Spry2 coordination is required for normal development of the external genitalia in mice

    Coordinated activity of Spry1 and Spry2 is required for normal development of the external genitalia.
    Ching ST, Cunha GR, Baskin LS, Basson MA, Klein OD., Free PMC Article

    03/22/2014
    We propose that Sprouty genes(Spry2 and Spry4) were implicated during evolution in reduction of the cheek teeth in Muridae, and their deletion can reveal ancestral stages of murine dental evolution.

    The dynamics of supernumerary tooth development are differentially regulated by Sprouty genes.
    Lagronova-Churava S, Spoutil F, Vojtechova S, Lesot H, Peterka M, Klein OD, Peterkova R.

    02/15/2014
    conjunctival epithelial Spry1 and Spry2 redundantly promote eyelid closure.

    Spry1 and Spry2 are necessary for eyelid closure.
    Kuracha MR, Siefker E, Licht JD, Govindarajan V., Free PMC Article

    12/28/2013
    Findings indicate that leukemia inhibitory factor (LIF)-induced Stat3 phosphorylation plays an important role in promoting the binding of phospho-Erk1/2 and Sprouty2, and thus inhibiting growth factor (FGF)-induced differentiation.

    Leukemia inhibitory factor-induced Stat3 signaling suppresses fibroblast growth factor 1-induced Erk1/2 activation to inhibit the downstream differentiation in mouse embryonic stem cells.
    Liu JW, Hsu YC, Kao CY, Su HL, Chiu IM.

    11/2/2013
    study thus reveals a novel Spry2 function, which mediates endothelial contact inhibition and barrier integrity

    Sprouty2 expression controls endothelial monolayer integrity and quiescence.
    Peier M, Walpen T, Christofori G, Battegay E, Humar R.

    09/7/2013
    firstprevious page of 3 nextlast